{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:48:08Z","timestamp":1776185288847,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA196510"],"award-info":[{"award-number":["P50CA196510"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002345"],"award-info":[{"award-number":["UL1TR002345"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1245\/s10434-024-16245-1","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T19:01:32Z","timestamp":1726945292000},"page":"8725-8733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plasma Ceramide C24:0\/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1245","volume":"31","author":[{"given":"Joshua D.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Panni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Fergestrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adetunji T.","family":"Toriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Nywening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Peter","family":"Goedegebuure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline L.","family":"Mudd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan C.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda R.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,21]]},"reference":[{"issue":"1","key":"16245_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clinicians. 2018;68(1):7\u201330.","journal-title":"CA Cancer J Clinicians."},{"key":"16245_CR2","volume-title":"Cancer facts & figures 2019","author":"Society AC","year":"2019","unstructured":"Society AC. Cancer facts & figures 2019. Atlanta: American Cancer Society; 2019."},{"issue":"5","key":"16245_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3322\/caac.21190","volume":"63","author":"CL Wolfgang","year":"2013","unstructured":"Wolfgang CL, Herman JM, Laheru DA, et al. Recent progress in pancreatic cancer. CA Cancer J Clinic. 2013;63(5):318\u201348.","journal-title":"CA Cancer J Clinic"},{"issue":"2","key":"16245_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13193-011-0042-1","volume":"2","author":"UK Ballehaninna","year":"2011","unstructured":"Ballehaninna UK, Chamberlain RS. Serum CA 19\u20139 as a biomarker for pancreatic cancer-a comprehensive review. Indian J Surg Oncol. 2011;2(2):88\u2013100.","journal-title":"Indian J Surg Oncol."},{"issue":"10","key":"16245_CR5","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2217\/fon.10.116","volume":"6","author":"S Ponnusamy","year":"2010","unstructured":"Ponnusamy S, Meyers-Needham M, Senkal CE, et al. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol. 2010;6(10):1603\u201324.","journal-title":"Future Oncol."},{"issue":"18","key":"16245_CR6","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1158\/1078-0432.CCR-11-0930","volume":"17","author":"SA Saddoughi","year":"2011","unstructured":"Saddoughi SA, Garrett-Mayer E, Chaudhary U, et al. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C\u2081\u2088-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011;17(18):6097\u2013105.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"16245_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1096\/fj.09-135087","volume":"24","author":"CE Senkal","year":"2010","unstructured":"Senkal CE, Ponnusamy S, Bielawski J, Hannun YA, Ogretmen B. Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6\/CHOP arm of ER-stress-response pathways. FASEB J. 2010;24(1):296\u2013308.","journal-title":"FASEB J."},{"issue":"5","key":"16245_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/carcin\/bgp061","volume":"30","author":"S Schiffmann","year":"2009","unstructured":"Schiffmann S, Sandner J, Birod K, et al. Ceramide synthases and ceramide levels are increased in breast cancer tissue. Carcinogenesis. 2009;30(5):745\u201352.","journal-title":"Carcinogenesis."},{"issue":"2","key":"16245_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bbamem.2014.11.018","volume":"1848","author":"J Stiban","year":"2015","unstructured":"Stiban J, Perera M. Very long chain ceramides interfere with C16-ceramide-induced channel formation: a plausible mechanism for regulating the initiation of intrinsic apoptosis. Biochim Biophys Acta. 2015;1848(2):561\u20137.","journal-title":"Biochim Biophys Acta."},{"issue":"7","key":"16245_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.biocel.2013.03.012","volume":"45","author":"D Hartmann","year":"2013","unstructured":"Hartmann D, Wegner MS, Wanger RA, et al. The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS. Int J Biochem Cell Biol. 2013;45(7):1195\u2013203.","journal-title":"Int J Biochem Cell Biol."},{"issue":"10","key":"16245_CR11","doi-asserted-by":"publisher","first-page":"e007931","DOI":"10.1161\/JAHA.117.007931","volume":"7","author":"LR Peterson","year":"2018","unstructured":"Peterson LR, Xanthakis V, Duncan MS, Gross S, Friedrich N, V\u00f6lzke H, Felix SB, Jiang H, Sidhu R, Nauck M, Jiang X. Ceramide remodeling and risk of cardiovascular events and mortality. J Am Heart Assoc. 2018;7(10):e007931.","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"16245_CR12","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1007\/s00216-013-7166-9","volume":"405","author":"H Jiang","year":"2013","unstructured":"Jiang H, Hsu FF, Farmer MS, et al. Development and validation of LC-MS\/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma. Anal Bioanal Chem. 2013;405(23):7357\u201365.","journal-title":"Anal Bioanal Chem."},{"issue":"3","key":"16245_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4236\/jct.2013.43096","volume":"4","author":"DE Sanford","year":"2013","unstructured":"Sanford DE, Porembka MR, Panni RZ, et al. A study of zoledronic acid as neo-adjuvant, perioperative therapy in patients with resectable pancreatic ductal adenocarcinoma. J Cancer Ther. 2013;4(3):797\u2013803.","journal-title":"J Cancer Ther."},{"issue":"5","key":"16245_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening TM, Wang-Gillam A, Sanford DE, et al. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol. 2016;17(5):651\u201362.","journal-title":"Lancet Oncol."},{"issue":"5","key":"16245_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","volume":"8","author":"S Durrleman","year":"1989","unstructured":"Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8(5):551\u201361.","journal-title":"Stat Med"},{"issue":"8","key":"16245_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/aje\/kwx149","volume":"186","author":"E Paige","year":"2017","unstructured":"Paige E, Barrett J, Pennells L, et al. Use of repeated blood pressure and cholesterol measurements to improve cardiovascular disease risk prediction: an individual-participant-data meta-analysis. Am J Epidemiol. 2017;186(8):899\u2013907.","journal-title":"Am J Epidemiol."},{"issue":"18","key":"16245_CR17","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr","year":"1982","unstructured":"Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543\u20136.","journal-title":"JAMA."},{"key":"16245_CR18","unstructured":"Allison PD. Logistic regression using the SAS system: theory and application. SAS Institute; 2008."},{"key":"16245_CR19","volume-title":"Shingolipids and metabolic disease: landes bioscience and springer","author":"SE Brice","year":"2011","unstructured":"Brice SE, Cowart LA. Shingolipid metabolism and analysis in metabolic disease. In: LA Cowart, editor. Shingolipids and metabolic disease: landes bioscience and springer. Cham; 2011."},{"issue":"8","key":"16245_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00018-022-04401-3","volume":"79","author":"P Hammerschmidt","year":"2022","unstructured":"Hammerschmidt P, Bruning JC. Contribution of specific ceramides to obesity-associated metabolic diseases. Cell Mol Life Sci. 2022;79(8):395.","journal-title":"Cell Mol Life Sci."},{"issue":"5","key":"16245_CR21","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms23052719","volume":"23","author":"M Gaggini","year":"2022","unstructured":"Gaggini M, Ndreu R, Michelucci E, Rocchiccioli S, Vassalle C. Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease. Int J Mol Sci. 2022;23(5):2719.","journal-title":"Int J Mol Sci"},{"issue":"12 Suppl","key":"16245_CR22","first-page":"S203","volume":"23","author":"S Alkaade","year":"2017","unstructured":"Alkaade S, Vareedayah AA. A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities. Am J Manag Care. 2017;23(12 Suppl):S203\u20139.","journal-title":"Am J Manag Care."},{"issue":"1","key":"16245_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41467-021-27765-9","volume":"13","author":"D Wolrab","year":"2022","unstructured":"Wolrab D, Jirasko R, Cifkova E, et al. Lipidomic profiling of human serum enables detection of pancreatic cancer. Nat Commun. 2022;13(1):124.","journal-title":"Nat Commun."},{"issue":"1","key":"16245_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3398","volume":"13","author":"SA Morad","year":"2013","unstructured":"Morad SA, Cabot MC. Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer. 2013;13(1):51\u201365.","journal-title":"Nat Rev Cancer."},{"issue":"22","key":"16245_CR25","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.1158\/0008-5472.CAN-04-2988","volume":"64","author":"DE Modrak","year":"2004","unstructured":"Modrak DE, Cardillo TM, Newsome GA, Goldenberg DM, Gold DV. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. Cancer Research. 2004;64(22):8405\u201310.","journal-title":"Cancer Research."},{"issue":"6","key":"16245_CR26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1541-7786.MCR-08-0457","volume":"7","author":"DE Modrak","year":"2009","unstructured":"Modrak DE, Leon E, Goldenberg DM, Gold DV. Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines. Mol Cancer Res. 2009;7(6):890\u20136.","journal-title":"Mol Cancer Res."},{"issue":"10","key":"16245_CR27","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","volume":"26","author":"B Chaurasia","year":"2015","unstructured":"Chaurasia B, Summers SA. Ceramides\u2014lipotoxic inducers of metabolic disorders. Trends Endocrinol Metab. 2015;26(10):538\u201350.","journal-title":"Trends Endocrinol Metab."},{"issue":"11","key":"16245_CR28","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1245\/s10434-017-5988-y","volume":"24","author":"AT Toriola","year":"2017","unstructured":"Toriola AT, Ziegler M, Li Y, Pollak M, Stolzenberg-Solomon R. Prediagnosis circulating insulin-like growth factors and pancreatic cancer survival. Ann Surg Oncol. 2017;24(11):3212\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"16245_CR29","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1038\/s41467-018-06650-y","volume":"9","author":"B Fekry","year":"2018","unstructured":"Fekry B, Jeffries KA, Esmaeilniakooshkghazi A, et al. C16-ceramide is a natural regulatory ligand of p53 in cellular stress response. Nat Commun. 2018;9(1):4149.","journal-title":"Nat Commun."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16245-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16245-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16245-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T13:07:23Z","timestamp":1731071243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16245-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,21]]},"references-count":29,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["16245"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16245-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,21]]},"assertion":[{"value":"14 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Linda Peterson and Xuntian Jang are both patent holders on the predictive value of the ceramide ratio for cardiovascular disease and congestive heart failure. Yin Cao previously served as a consultant for Geneoscopy for work unrelated to the topic. Joshua Mitchell has received research support from Abbott Laboratories, Myocardial Solutions, and Children\u2019s Discovery Institute, unrelated to this manuscript, and has also received modest consulting fees from Alnylam, BridgeBio, Jazz Pharmaceuticals, Pfizer, Race Oncology, and Altathera for work unrelated to this manuscript. Usman Panni, Nicole Fergestrom, Adetunji T. Toriola, Timothy M. Nywening, S. Peter Goedegebuure, Jacqueline L. Mudd, Joseph Ippolito, Ryan C. Fields, and William G. Hawkins declare no potential conflicts of interest that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}